Growth Metrics

Outset Medical (OM) Receivables - Net (2019 - 2025)

Outset Medical (OM) has disclosed Receivables - Net for 7 consecutive years, with $28.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 20.47% to $28.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.3 million, a 20.47% decrease, with the full-year FY2025 number at $28.3 million, down 20.47% from a year prior.
  • Receivables - Net was $28.3 million for Q4 2025 at Outset Medical, down from $33.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $36.9 million in Q2 2023 to a low of $12.1 million in Q1 2021.
  • A 5-year average of $29.4 million and a median of $33.0 million in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: soared 295.79% in 2021, then fell 20.47% in 2025.
  • Outset Medical's Receivables - Net stood at $25.6 million in 2021, then grew by 9.65% to $28.1 million in 2022, then rose by 17.49% to $33.0 million in 2023, then increased by 8.0% to $35.6 million in 2024, then decreased by 20.47% to $28.3 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Receivables - Net are $28.3 million (Q4 2025), $33.0 million (Q3 2025), and $34.9 million (Q2 2025).